5-hydroxydecanoate and sarpogrelate

5-hydroxydecanoate has been researched along with sarpogrelate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arai, M; Chen, X; Fujiwara, H; Fujiwara, T; Hashimoto, K; Lu, C; Minatoguchi, S; Shimizu, Y; Shimomura, M; Takemura, G; Uno, Y; Wang, N	1

Other Studies

1 other study(ies) available for 5-hydroxydecanoate and sarpogrelate

Article	Year
The role of serotonin in ischemic cellular damage and the infarct size-reducing effect of sarpogrelate, a 5-hydroxytryptamine-2 receptor blocker, in rabbit hearts. Journal of the American College of Cardiology, 2002, Oct-02, Volume: 40, Issue:7 Topics: Adenosine Triphosphate; Alkaloids; Animals; Benzophenanthridines; Decanoic Acids; Disease Models, Animal; Drug Evaluation, Preclinical; Hemodynamics; Hydroxy Acids; In Vitro Techniques; Isoenzymes; Myocardial Infarction; Phenanthridines; Potassium Channel Blockers; Protein Kinase C; Protein Kinase C-epsilon; Rabbits; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Succinates	2002

Article

Year

The role of serotonin in ischemic cellular damage and the infarct size-reducing effect of sarpogrelate, a 5-hydroxytryptamine-2 receptor blocker, in rabbit hearts.

Journal of the American College of Cardiology, 2002, Oct-02, Volume: 40, Issue:7

Topics: Adenosine Triphosphate; Alkaloids; Animals; Benzophenanthridines; Decanoic Acids; Disease Models, Animal; Drug Evaluation, Preclinical; Hemodynamics; Hydroxy Acids; In Vitro Techniques; Isoenzymes; Myocardial Infarction; Phenanthridines; Potassium Channel Blockers; Protein Kinase C; Protein Kinase C-epsilon; Rabbits; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Succinates

2002